CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: Doramectin
Accession: CHEBI:31516
browse the term
Synonyms: related_synonym: Formula=C50H74O14; InChI=1S/C50H74O14/c1-27-13-12-16-34-26-57-47-42(51)30(4)21-37(50(34,47)54)48(53)60-36-22-35(63-49(25-36)20-19-29(3)45(64-49)33-14-10-9-11-15-33)18-17-28(2)44(27)61-41-24-39(56-8)46(32(6)59-41)62-40-23-38(55-7)43(52)31(5)58-40/h12-13,16-17,19-21,27,29,31-33,35-47,51-52,54H,9-11,14-15,18,22-26H2,1-8H3/b13-12+,28-17+,34-16+/t27-,29-,31-,32-,35+,36-,37-,38?,39-,40-,41-,42+,43-,44-,45-,46-,47+,49+,50+/m0/s1; InChIKey=QLFZZSKTJWDQOS-DLZZRMBFSA-N; SMILES=[C@@]12(O[C@@H]([C@@H](C)C=C1)C3CCCCC3)C[C@@H]4C[C@](O2)(CC=C([C@@H](O[C@H]5C[C@@H]([C@@H](O[C@H]6CC([C@@H](O)[C@@H](O6)C)OC)[C@@H](O5)C)OC)[C@H](C=CC=C7[C@]8([C@H](C(O4)=O)C=C(C)[C@H]([C@]8(OC7)[H])O)O)C)C)[H]
xref: CAS:117704-25-3; KEGG:D01129
xref_mesh: MESH:C084101
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression decreases activity
ISO
doramectin results in decreased expression of ABCB1 mRNA; doramectin results in decreased expression of ABCB1 protein doramectin results in decreased expression of ABCB1A protein doramectin results in decreased activity of ABCB1A protein
CTD
PMID:17134887 PMID:19879343 PMID:20487225
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Actb
actin, beta
decreases expression
ISO
doramectin results in decreased expression of ACTB protein
CTD
PMID:19879343
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Akt1
AKT serine/threonine kinase 1
decreases expression
EXP
doramectin results in decreased expression of AKT1 mRNA
CTD
PMID:35137919
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Ano1
anoctamin 1
decreases activity
ISO
doramectin results in decreased activity of ANO1 protein
CTD
PMID:32201246
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
G
Atg5
autophagy related 5
increases expression
EXP ISO
doramectin results in increased expression of ATG5 protein
CTD
PMID:35137919
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Dapk1
death associated protein kinase 1
decreases expression
EXP
doramectin results in decreased expression of DAPK1 mRNA
CTD
PMID:35137919
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Deptor
DEP domain containing MTOR-interacting protein
decreases expression
EXP
doramectin results in decreased expression of DEPTOR mRNA
CTD
PMID:35137919
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Eif2ak4
eukaryotic translation initiation factor 2 alpha kinase 4
decreases expression
EXP
doramectin results in decreased expression of EIF2AK4 mRNA
CTD
PMID:35137919
NCBI chr 3:105,356,261...105,441,630
Ensembl chr 3:105,356,261...105,441,630
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
EXP
doramectin results in decreased expression of IGF1R mRNA
CTD
PMID:35137919
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
decreases expression
EXP
doramectin results in decreased expression of ITPR1 mRNA
CTD
PMID:35137919
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions
ISO EXP
doramectin results in increased expression of and results in increased lipidation of MAP1LC3A protein Chloroquine inhibits the reaction [doramectin results in decreased expression of and results in increased lipidation of MAP1LC3A protein]; Chloroquine inhibits the reaction [doramectin results in decreased expression of MAP1LC3A protein]; doramectin results in decreased expression of and results in increased lipidation of MAP1LC3A protein; doramectin results in increased expression of and results in increased lipidation of MAP1LC3A protein
CTD
PMID:35137919
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Mras
muscle RAS oncogene homolog
decreases expression
EXP
doramectin results in decreased expression of MRAS mRNA
CTD
PMID:35137919
NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
EXP
doramectin results in decreased expression of MTOR mRNA
CTD
PMID:35137919
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions
ISO
doramectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]]
CTD
PMID:27773686
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
doramectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]]; doramectin inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]; doramectin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666 PMID:27773686
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
decreases expression
EXP
doramectin results in decreased expression of PIK3CB mRNA
CTD
PMID:35137919
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
decreases expression
EXP
doramectin results in decreased expression of PIK3CD mRNA
CTD
PMID:35137919
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
EXP
doramectin results in decreased expression of PIK3R3 mRNA
CTD
PMID:35137919
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
EXP
doramectin results in decreased expression of PRKACA mRNA
CTD
PMID:35137919
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
decreases expression
EXP
doramectin results in decreased expression of PRKACB mRNA
CTD
PMID:35137919
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
G
Rragd
Ras-related GTP binding D
increases expression
EXP
doramectin results in increased expression of RRAGD mRNA
CTD
PMID:35137919
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
G
Sqstm1
sequestosome 1
decreases expression multiple interactions
EXP ISO
doramectin results in decreased expression of SQSTM1 protein Chloroquine inhibits the reaction [doramectin results in decreased expression of SQSTM1 protein]
CTD
PMID:35137919
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Tp53inp2
tumor protein p53 inducible nuclear protein 2
decreases expression
EXP
doramectin results in decreased expression of TP53INP2 mRNA
CTD
PMID:35137919
NCBI chr 3:143,881,427...143,890,104
Ensembl chr 3:143,882,021...143,890,097
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
doramectin results in decreased expression of TUBB3 protein
CTD
PMID:19879343
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all